Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The following table summarizes our share-based compensation expense, which consists of RSU expense, by line item in our condensed consolidated statements of income (in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Cost of revenue	$	266	$	183	$	775	$	536
Research and development	3,486		2,881		10,178		8,635
Marketing and sales	260		219		773		727
General and administrative	238		209		702		705
Total share-based compensation expense	$	4,250	$	3,492	$	12,428	$	10,603

Restricted Stock Units Award Activity

The following table summarizes the activities for our unvested RSUs for the nine months ended September 30, 2024:

	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Unvested at December 31, 2023	149,062	$	209.85
Granted	45,343	$	501.88
Vested	(48,916)	$	245.36
Forfeited	(8,142)	$	246.92
Unvested at September 30, 2024	137,347	$	291.41